Heart failure patients in India have higher mortality rate post-diagnosis: Study

Patients reaching hospitals at a later stage a major reason for this, says a contributor to the global study

June 21, 2017 11:44 pm | Updated 11:44 pm IST - Bengaluru

Indians have one of the highest rates of mortality after diagnosis of heart failure, greater than that of people in several developing countries in the world, according to a study published in the The Lancet Global Health.

The study, published on May 2, has found that heart failure patients in India had one of the highest mortality rates after one year of diagnosis at 23%. This was more than mortality rates of patients in Southeast Asia (15%), China (7%), South America (9%) and West Asia (9%). Only patients from countries in Africa had a higher mortality rate at 34%. The study also highlighted that heart failure patients in India, Africa and Southeast Asia were approximately 10 years younger than patients in the U.S. and Europe.

The India component of the study was led by Dorairaj Prabhakaran, vice-president (Research & Policy), Public Health Foundation of India, New Delhi; and Ambuj Roy, professor of Cardiology, All India Institute of Medical Science, New Delhi. Of the 5,823 heart failure patients observed in India, Africa, Southeast Asia, China, South America, and West Asia, two-thirds were clinic outpatients. The study was funded by pharmaceutical company Novartis.

According to Dr. Prabhakaran, one of the major reasons for the high mortality rate among Indians was that patients reached hospitals at a later stage of the disease, along with an associated high prevalence of risk factors such as diabetes and hypertension.

“In other countries, patients may present to hospitals earlier. Access to healthcare and compliance to long-term treatment is also a problem in India, as heart failure patients need to take lifelong medications,” said Dr. Prabhakaran. Of the 858 patients observed in India, an equal number were from urban and rural centres. “We wanted a non-metro representation so patients were taken from all parts of the country,” said Dr. Roy, and added that this was one of the first studies comparing global mortality rates for heart failure patients.

Need for better health coverage

He pointed out that while the predisposition of Indians to lifestyle diseases at a younger age is known, the study highlights the need for better health coverage, particularly in rural settings. “Rural health setups in India are not equipped to handle non-communicable diseases such as diabetes, hypertension and heart failure, which need regular follow-up; they are more geared towards containing communicable diseases,” said Dr. Roy.

Another area of note was the low permeance of medical insurance. According to the AIIMS professor, only 19% of patients from India who were part of the study were insured, the lowest across countries. This meant that even after diagnosis, many patients dropped out of treatment.

Hisham Dokainish, principal investigator, Population Health Research Institute, Hamilton, Canada; who is the corresponding author of the study, said that after accounting for 20 demographic, clinical, treatment and socio-economic variables, Indian patients were at approximately three times the risk of death within one year compared with heart failure patients in relatively higher income regions observed in the study, including West Asia, China and South America.

“We can only speculate the reasons for this, which include healthcare access, quality, infrastructure, genomic and genetic factors, environmental factors, and adherence to and availability of evidence-based medicines for heart failure,” said Dr. Dokainish.

Heart failure is a condition in which the heart is unable to pump enough blood to meet the body’s needs. The heart doesn’t stop beating, as happens in a cardiac arrest, but rather weakens so that it is unable to pump out all the blood that enters in chambers, either due to weakness or stiffness of heart muscle.

Other institutes involved in the study include the Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China; King Fahad Cardiac Center, Riyadh, Saudi Arabia; and other institutes in Sudan, Philippines, Colombia, Malaysia, Argentina, South Africa, Chile, Qatar, Tanzania, Mozambique, and Chicago.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.